{
  "meta": {
    "title": "Primary_Angle_Closure_Glaucoma_Primary_Open_Angle_Glaucoma",
    "url": "https://brainandscalpel.vercel.app/primary-angle-closure-glaucoma-primary-open-angle-glaucoma-830fa43b.html",
    "scrapedAt": "2025-11-29T18:31:16.595Z"
  },
  "questions": [
    {
      "id": 15192,
      "choices": [
        {
          "id": 60728,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Latanoprost </span></span></span></span></p>"
        },
        {
          "id": 60729,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B<span style=\"color:black\">rimonidine</span></span></span></span></p>"
        },
        {
          "id": 60730,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Timolol</span></span></span></span></p>"
        },
        {
          "id": 60731,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A<span style=\"color:black\">ll of the above</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 55-year-old man presents to an ophthalmologist with occasional headaches and no specific vision complaints. The examination reveals increased cupping of the optic disc, visual field defects, and elevated intraocular pressure. A diagnosis of primary open-angle glaucoma is made. Treatment is initiated with topical eye drops and regular follow-up visits are scheduled. The following finding is noticed on a follow-up visit. Which drug(s) is/are responsible for it?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture3_KYavGOe.jpg\" style=\"height:241px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q9228731",
      "question_audio": null,
      "question_video": null,
      "map_id": 31236,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Latanoprost </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image shows <strong>Long, Thick Eyelashes</strong> which is a <strong>side-effect</strong> of <strong>Prostaglandin analogues</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostaglandin Analogues</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Travoprost</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bimatoprost</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tafluprost</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Side effects&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of <strong>Prostaglandin Analogues</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Conjunctival Hyperemia</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Eyelash L</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">engthening<span style=\"color:black\">, Thickening, Hyperpigmentation</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Irreversible Iris Hyperpigmentation</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Reversible Hyperpigmentation of Periocular Skin</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Increased risk of Cystoid Macular Edema following Cataract Surgery</span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">A <strong>well-documented side effect</strong> of <strong>Prostaglandin Analogs</strong>, including <strong>Latanoprost</strong>, is <strong>increased</strong> <strong>Eyelash Growth</strong>, or <strong>Hypertrichosis</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kanski&rsquo;s Clinical Ophthalmology, 8<sup>th</sup> Edition, Page 331</span></span></strong></p>",
      "correct_choice_id": 60728,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15218,
      "choices": [
        {
          "id": 60832,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">30 degrees&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 60833,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">90 degree<span style=\"color:black\">s&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 60834,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">60 degrees&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 60835,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">40 degrees&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 45-year-old patient with a family history of glaucoma visits the ophthalmologist for a routine examination. Her IOP is measured, optic disc and angle of anterior chamber are examined. On gonioscopy, Schlemm&rsquo;s canal, trabecular meshwork, scleral spur and ciliary body band are visible. What is the angle width?</span></span></span></span></p>",
      "unique_key": "Q6447633",
      "question_audio": null,
      "question_video": null,
      "map_id": 31232,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 40 degrees</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As given in the diagram and table below, when <strong>all 4 structures</strong> are <strong>visible</strong>, the <strong>angle subtended</strong> is <strong>40</strong></span><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">&deg;&nbsp;</span></span></span></strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\">indicating the patient has a <strong>wide open angle</strong>, with no chance of closure.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture30.jpg\" style=\"height:241px; width:400px\" /></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#333333\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-122813.jpg\" style=\"height:379px; width:1000px\" /></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In an <strong>angle</strong> with a <strong>width</strong> of <strong>30 degrees</strong>, <strong>SL, TM, SS</strong> are the <strong>only angle structures</strong> seen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B &amp; C:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>90 degree</strong> and <strong>60 Degree</strong> configurations are <strong>not described</strong> for angle structures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on the <strong>visibility</strong> of <strong>all the listed structures</strong> (<strong>Schlemm&rsquo;s canal</strong>, <strong>trabecular meshwork</strong>, <strong>scleral spur</strong>, and <strong>ciliary body band</strong>), the correct answer is <strong>D</strong>. <strong>40 degrees</strong>, indicating a <strong>wide-open angle</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Comprehensive Ophthalmology, A K Khurana, 5<sup>th</sup> Edition, Page 220</span></strong></span></span></p>",
      "correct_choice_id": 60835,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15190,
      "choices": [
        {
          "id": 60720,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Glaukomflecken</span></p>"
        },
        {
          "id": 60721,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Dilated Non Reacting Pupil</span></p>"
        },
        {
          "id": 60722,
          "text": "<p><span style=\"font-size:12pt;\">I</span><span style=\"color:black;font-size:12pt;\">ris Atrophy</span></p>"
        },
        {
          "id": 60723,
          "text": "<p><span style=\"font-size:12pt;\">G</span><span style=\"color:black;font-size:12pt;\">oniosynechiae</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Which of the following is not part of Vogt's triad following an episode of acute primary angle closure glaucoma?</span></p>",
      "unique_key": "Q6282302",
      "question_audio": null,
      "question_video": null,
      "map_id": 31234,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"color:black;font-size:12pt;\"><strong>Ans. D)&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>G</strong></span><span style=\"color:black;font-size:12pt;\"><strong>oniosynechiae</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option D.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\">Goniosynechiae refer to <strong>iridiotrabecular adhesions</strong> of the <strong>peripheral iris</strong> to the <strong>trabecular meshwork</strong>. It is not a part of Vogt’s triad.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-105641.jpg\" alt=\"\" width=\"400\" height=\"301\"></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12pt;\">Vogt’s triad is seen in <strong>both treated</strong> and <strong>untreated cases</strong> after an <strong>attack</strong> of <strong>acute PAC glaucoma</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option A. Glaucomflecken&nbsp;</strong>(Anterior Subcapsular Lenticular Opacity). These are the <strong>small</strong>, <strong>white</strong>, <strong>opaque spots</strong> on the <strong>lens</strong> indicative of <strong>previous acute attacks</strong>.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture2_2mgFEdt.jpg\" alt=\"\" width=\"300\" height=\"199\"></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option B</strong>. <strong>Slightly dilated non-reacting pupil</strong> due to <strong>sphincter atrophy</strong>.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong>Option C.&nbsp;</strong>Patches of iris atrophy occurs due to <strong>ischemia</strong> from the <strong>prolonged contact</strong> between the <strong>iris</strong> and the <strong>trabecular meshwork</strong>.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\"><strong><u>Educational Objective</u></strong><u>:</u></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12pt;\">The components of <strong>Vogt's triad</strong> for <strong>primary angle closure glaucoma</strong> include <strong>glaukomflecken</strong>, <strong>iris atrophy</strong>, and <strong>mid-dilated pupil</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref:&nbsp;</u>Comprehensive Ophthalmology, A K Khurana, 5<sup>th</sup> edition, page 245</strong></span></p>",
      "correct_choice_id": 60723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15206,
      "choices": [
        {
          "id": 60784,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Primary Open Angle Glaucoma&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 60785,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pseudo-Exfoliation Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60786,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Acute Angle Closure Attack&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 60787,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Primary Angle Closure Glaucoma</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 40-year-old male came to the OPD with complaints of sudden onset Severe Pain in Right Eye since morning. Examination showed Circumcorneal Congestion &amp; Shallow Anterior Chamber. What is the probable Diagnosis?</span></span></span></p>",
      "unique_key": "Q2759459",
      "question_audio": null,
      "question_video": null,
      "map_id": 31229,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C) Acute Angle Closure Attack</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Acute Angle Closure Glaucoma occurs when there is a <strong>relatively sudden blockage</strong> of the <strong>trabecular meshwork</strong> leading to <strong>obstruction</strong> in <strong>Aqueous Humor outflow</strong> and consequently causing <strong>elevation</strong> of the <strong>Intraocular Pressure</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">One possible mechanism is the <strong>Anterior Bulging</strong> of the <strong>Peripheral Iris</strong>, occluding the <strong>Trabecular Meshwork</strong> and <strong>trapping Aqueous Humor</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T<span style=\"color:black\">he reason for the <strong>sudden Anterior Bulging</strong> of the <strong>Peripheral Iris</strong> may be due to <strong>Pupillary Block</strong> (where the lens presses up <strong>against</strong> the <strong>iris trapping</strong> all the <strong>Aqueous Humor</strong> behind it).</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture19.jpg\" style=\"height:256px; width:350px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. Primary open-angle glaucoma: <strong>Insidious onset</strong> and usually <strong>asymptomatic</strong> initially with <strong>mild headache</strong> and <strong>ocular pain</strong>. May have history of frequent change in near vision glasses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. Pseudo-Exfoliation Glaucoma: <strong>Amorphous grey</strong> dandruff-like <strong>material deposition</strong> on <strong>pupillary border</strong>, <strong>anterior lens surface,</strong> <strong>posterior iris surface</strong>, <strong>zonules</strong>, <strong>ciliary process</strong> and <strong>blockage</strong> of <strong>trabecular meshwork</strong> with the <strong>same</strong>. Clinically usually behaves like <strong>POAG</strong>, but can present as ACG also.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. Primary Angle Closure Glaucoma: Can present with <strong>intermittent symptoms</strong> of <strong>Blurring</strong> and <strong>Haloes</strong> due to <strong>Corneal Epithelial Oedema</strong> or acutely with markedly <strong>Decreased Vision</strong> and <strong>Ocular/Periocular Pain</strong> and <strong>Headache</strong> (like in the question, for which a more suitable answer is <strong>Acute Angle Closure Attack</strong>).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Recognize the <strong>classic presentation</strong> of an <strong>Acute Angle-Closure Attack</strong>, which includes <strong>sudden onset</strong> of <strong>severe Ocular Pain</strong>, <strong>Circumcorneal Congestion</strong>, and a <strong>shallow Anterior Chamber</strong>, requiring prompt <strong>recognition</strong> and <strong>management</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Comprehensive Ophthalmology, A K Khurana, 5<sup>th</sup> Edition, Page 244</span></strong></span></span></p>",
      "correct_choice_id": 60786,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15255,
      "choices": [
        {
          "id": 60980,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Reduces Aqueous Production</span></span></span></span></p>"
        },
        {
          "id": 60981,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Increases Trabecular Outflow</span></span></span></span></p>"
        },
        {
          "id": 60982,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Increases Uveoscleral Outflow</span></span></span></span></p>"
        },
        {
          "id": 60983,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">All of the above</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">A 65-year-old female with a family history of glaucoma undergoes a routine eye examination. She is asymptomatic but on examination it seen that her intraocular pressure is raised, and further evaluation reveals early-stage optic nerve damage. She is diagnosed with primary open angle glaucoma and is given a beta-blocker. What is the mode of action of beta-blockers?</span></span></span></p>",
      "unique_key": "Q8271852",
      "question_audio": null,
      "question_video": null,
      "map_id": 31235,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ans. A) Reduces Aqueous Production.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option A: Beta-blockers:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#212121\"><strong>Mode of Action:</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"><strong>Reduce IOP</strong> by <strong>Reducing Aqueous production</strong> by <strong>effect</strong> on <strong>Ciliary Epithelium</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Contraindications:</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Asthma</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Cardiovascular disease</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Peripheral vascular disease</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Instillation as bedtime: (not to be done) as this medication may cause a significant drop in BP while the individual is asleep, thus reducing optic disc perfusion and potentially causing visual field deterioration.</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Agents:</span></span></strong></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Timolol</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Betaxolol (relatively cardioselective)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Levobunolol</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Carteolol</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option B. Increases Trabecular Outflow&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">is <strong>not</strong> the <strong>primary action</strong> of <strong>beta-blockers</strong>. Drugs that <strong>increase trabecular outflow</strong> are typically <strong>prostaglandin analogs</strong> or <strong>cholinergic agents</strong>, not beta-blockers.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option C.&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Like increasing trabecular outflow, this is <strong>not</strong> a <strong>mechanism</strong> of <strong>action</strong> for <strong>beta-blockers</strong>. <strong>Increasing uveoscleral outflow</strong> is a <strong>mechanism</strong> associated with <strong>prostaglandin analogs</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Beta Blockers</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"> <strong>reduce</strong> <strong>intraocular pressure</strong> by <strong>reducing aqueous production</strong> in the eye.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ref:&nbsp;</span></span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Kanski&rsquo;s&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical Ophthalmology, 8<sup>th</sup> Edition, Page <span style=\"color:#212121\">331 </span></span></span></strong></p>",
      "correct_choice_id": 60980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15257,
      "choices": [
        {
          "id": 60988,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Goniotomy</span></span></span></span></p>"
        },
        {
          "id": 60989,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Iridectomy</span></span></span></span></p>"
        },
        {
          "id": 60990,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Laser Iridotomy</span></span></span></span></p>"
        },
        {
          "id": 60991,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Trabeculectomy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">A 42-year-old female patient diagnosed with angle closure glaucoma in right eye is planned for a prophylactic procedure in the left eye. The procedure is done and post-op eye is shown below. What is the prophylactic measure taken in this eye?</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture41.jpg\" style=\"height:179px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q2508707",
      "question_audio": null,
      "question_video": null,
      "map_id": 31237,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ans. C) Laser Iridotomy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">In this image, note the circular opening at 9&rsquo;0 Clock. This is the site of iridotomy.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">In <strong>primary angle closure glaucoma</strong>, there is <strong>appositional closure</strong> of <strong>angle</strong> of <strong>anterior chamber</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">This leads to <strong>accumulation</strong> of <strong>aqueous humour</strong> in the <strong>posterior chamber and consequently leads</strong> to <strong>anterior bowing</strong> of <strong>iris</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Treatment: <strong>Laser iridotomy&nbsp;</strong>is done along with <strong>medical therapy</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Prophylactic Laser iridotomy&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">is done in the other eye.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option A.&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Goniotomy is a <strong>surgical procedure</strong> done to <strong>create</strong> an <strong>opening</strong> in the <strong>trabecular meshwork</strong>. It can be done by <strong>two approaches</strong>, <strong>ab-interno</strong> and <strong>ab-externo</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture42.jpg\" style=\"height:200px; width:350px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option B:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Iridectomy is a procedure in which a <strong>section</strong> of the <strong>iris</strong> is <strong>incised</strong> through a <strong>scleral</strong> or <strong>limbal incision</strong>. It is a part of <strong>trabeculectomy surgery</strong>. Additionally, <strong>prophylactic surgical iridectomy</strong> is done in cases where there is a <strong>chance</strong> of <strong>postoperative pupillary block glaucoma</strong>, such as in cases of <strong>uveitis</strong>, in cases with <strong>silicone oil injection</strong> or <strong>air/gas injection</strong> in <strong>eye</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture43.jpg\" style=\"height:468px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option D:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Trabeculectomy &ndash; It is a <strong>glaucoma surgery</strong> where a <strong>subconjunctival filtering bleb</strong> is created via a <strong>scleral flap</strong> to <strong>drain intraocular aqueous</strong> and <strong>reduce intraocular pressure</strong>, <strong>bypassing</strong> the <strong>trabecular meshwork</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture44.jpg\" style=\"height:194px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">A well circumscribed <strong>opening</strong> in the <strong>midperipheral iris</strong> is <strong>suggestive</strong> of <strong>iridotomy</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ref:&nbsp;</span></span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Comprehensive&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ophthalmology, A K Khurana, 5<sup>th</sup> edition, page 249</span></strong></span></span></p>",
      "correct_choice_id": 60990,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15259,
      "choices": [
        {
          "id": 60996,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Argon</span></span></span></span></p>"
        },
        {
          "id": 60997,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Nd:YAG</span></span></span></span></p>"
        },
        {
          "id": 60998,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Krypton</span></span></span></span></p>"
        },
        {
          "id": 60999,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Both A &amp; B</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">A 63-year-old female who presented to the ophthalmologist with acute onset of severe pain and diminution of vision in the left eye was diagnosed with angle closure glaucoma. She was given medications to control her IOP and was posted for Laser peripheral iridotomy. Which laser will be used for this procedure?</span></span></span></p>",
      "unique_key": "Q6677839",
      "question_audio": null,
      "question_video": null,
      "map_id": 31238,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ans. D) Both A &amp; B </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Laser Peripheral Iridotomy&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">requires <strong>Argon</strong> or <strong>Nd:YAG laser</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">It is done if <strong>Peripheral Anterior Synechiae (PAS)</strong> is <strong>more than</strong> <strong>270 degrees</strong> of <strong>angle</strong>. Done at <strong>mid-peripheral iris</strong> <strong>1</strong> or <strong>11 o&rsquo;clock position.</strong></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Establishes communication between <strong>anterior</strong> &amp; <strong>posterior chamber</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">So, it <strong>bypasses</strong> the <strong>pupillary block</strong> &amp; <strong>relieves</strong> <strong>crowding</strong> of <strong>angle</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/12.jpg\" style=\"height:380px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#212121\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"><strong>Krypton Red laser</strong> was historically used for <strong>retinal photocoagulation</strong>. Not very commonly used now.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">For <strong>peripheral iridotomy,</strong> both <strong>Argon</strong> and <strong>Nd:YAG laser</strong> are used.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ref:&nbsp;</span></span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Comprehensive&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ophthalmology, A K Khurana, 5<sup>th</sup> Edition, Page 245</span></strong></span></span></p>",
      "correct_choice_id": 60999,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15261,
      "choices": [
        {
          "id": 61004,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol </span></span></span></p>"
        },
        {
          "id": 61005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide </span></span></span></p>"
        },
        {
          "id": 61006,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apraclonidine </span></span></span></p>"
        },
        {
          "id": 61007,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient underwent prophylactic Nd:YAG peripheral iridotomy. Which of the following agents is prescribed to counter post procedure spike in IOP?</span></span></span></p>",
      "unique_key": "Q2112366",
      "question_audio": null,
      "question_video": null,
      "map_id": 31239,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Apraclonidine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Apraclonidine is an <strong>alpha-2 adrenergic agonist</strong> that <strong>decreases IOP</strong> by <strong>reducing aqueous humor</strong> production and <strong>increasing uveoscleral outflow</strong>. It is often used specifically to <strong>prevent</strong> or <strong>treat spikes</strong> in <strong>IOP</strong> <strong>after laser eye surgery</strong>, making it an <strong>appropriate choice</strong> in this context. It has a <strong>rapid onset</strong> of <strong>action</strong>, which is <strong>beneficial</strong> for <strong>acute management post-procedure</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EXPLANATION:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Timolol is a <strong>beta-blocker</strong> used <strong>topically</strong> in the <strong>eye</strong> to <strong>reduce IOP</strong> by <strong>decreasing</strong> the production of <strong>aqueous humor</strong> by the <strong>ciliary body</strong>. It is <strong>effective</strong> in <strong>managing chronic open-angle glaucoma</strong> and can be used to <strong>control IOP spikes</strong>. However, it might not be the first choice immediately post-laser procedures due to its mechanism of action and time to onset.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Dorzolamide is a <strong>topical carbonic anhydrase inhibitor</strong> that <strong>reduces IOP</strong> by <strong>decreasing</strong> the production of aqueous humor in the eye. Like Timolol, it is used in the <strong>treatment</strong> of <strong>open-angle glaucoma</strong> and <strong>ocular hypertension</strong>. While effective, its mechanism also involves a <strong>decrease</strong> in <strong>aqueous production</strong>, and there might be more <strong>immediate</strong> and <strong>effective options</strong> for <strong>acute IOP spikes</strong> <strong>post-laser procedures</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Pilocarpine is a <strong>cholinergic agonist</strong> that <strong>works</strong> by <strong>constricting</strong> the <strong>pupil</strong> and <strong>pulling</strong> the <strong>iris away</strong> from the <strong>trabecular meshwork</strong>, <strong>increasing</strong> the outflow of <strong>aqueous humor</strong> and thus <strong>lowering IOP</strong>. It is used in the management of <strong>angle-closure glaucoma</strong>. However, in the context of <strong>post-iridotomy care</strong>, its use might be <strong>less relevant</strong> since the <strong>iridotomy</strong> itself is <strong>intended</strong> to <strong>relieve pupillary block</strong>, and further constriction of the pupil might not be necessary or beneficial.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the <strong>management</strong> of a <strong>post-procedure spike</strong> in <strong>intraocular pressure (IOP)</strong> following <strong>prophylactic Nd:YAG peripheral iridotomy</strong>, Apraclonidine is prescribed due to its <strong>rapid onset</strong> and <strong>effectiveness</strong> in <strong>reducing IOP</strong> by <strong>decreasing aqueous humor production</strong> and <strong>increasing uveoscleral outflow</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PARSONS DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 157</span></span></strong></p>",
      "correct_choice_id": 61006,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15276,
      "choices": [
        {
          "id": 61064,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brinzolamide </span></span></span></p>"
        },
        {
          "id": 61065,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol </span></span></span></p>"
        },
        {
          "id": 61066,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost </span></span></span></p>"
        },
        {
          "id": 61067,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old asthmatic male presents to an ophthalmology clinic with complaints of gradual vision loss and occasional headaches. Examination reveals optic nerve damage and visual field defects consistent with primary open-angle glaucoma (POAG). Intraocular pressure is elevated, and the patient&#39;s cup-to-disc ratio is increased. The first line management for POAG is medical, by drugs that lower intraocular pressure. All of the following can be prescribed to him, except?</span></span></p>",
      "unique_key": "Q2098257",
      "question_audio": null,
      "question_video": null,
      "map_id": 31230,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Timolol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Common <strong>side effects</strong> of <strong>beta blockers</strong> are <strong>dry eye</strong>, <strong>bradycardia</strong>, <strong>bronchial spasms</strong>, <strong>depression</strong>, and <strong>fatigue</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Brinzolamide&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>topical carbonic anhydrase inhibitor</strong> used in the treatment of <strong>glaucoma</strong>. It works by <strong>decreasing</strong> the <strong>production</strong> of <strong>aqueous humour</strong> in the <strong>eye</strong>. It does not typically exacerbate bronchial asthma and is generally <strong>considered safe</strong> for use in patients with this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Latanoprost&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>prostaglandin analogue</strong>, another class of medications used to treat glaucoma. It works by <strong>increasing</strong> the <strong>outflow</strong> of <strong>aqueous humour</strong> from the eye. Prostaglandin analogues are not known to adversely affect asthma and are <strong>generally safe</strong> for <strong>asthmatic patients</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Dorzolamide,&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">similar to brinzolamide, dorzolamide is a <strong>topical carbonic anhydrase inhibitor</strong> and is considered safe for use in patients with <strong>bronchial asthma</strong> as it typically does not exacerbate the condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systemic absorption&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of <strong>Timolol</strong> can <strong>potentially affect</strong> the <strong>respiratory system</strong>, and it can <strong>exacerbate bronchial asthma</strong> by <strong>causing bronchoconstriction</strong>. <strong>Beta-blockers</strong> are generally <strong>contraindicated</strong> in patients with <strong>asthma</strong> due to this risk.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parsons Diseases of Eye 22<sup>nd</sup> Edition Page: 157</span></span></strong></p>",
      "correct_choice_id": 61065,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15277,
      "choices": [
        {
          "id": 61068,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mannitol </span></span></span></p>"
        },
        {
          "id": 61069,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PG Analogues </span></span></span></p>"
        },
        {
          "id": 61070,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycerol </span></span></span></p>"
        },
        {
          "id": 61071,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 52-year-old female had gone for a movie when she started to complaint of a sudden onset of severe pain in her right eye for which she immediately came to the ophthalmologist. On taking history, it is learnt that she has no co-morbidities and is allergic to sulfa drugs. On examination, a congested conjunctiva is noticed with shallow AC, closed angle and very high IOP. A diagnosis of acute congestive glaucoma is made. Which of the following drugs needs to be avoided in this patient?</span></span></p>",
      "unique_key": "Q7119777",
      "question_audio": null,
      "question_video": null,
      "map_id": 31231,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Acetazolamide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>carbonic anhydrase inhibitor</strong> for <strong>systemic use</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sulfonamide&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(&lsquo;sulfa&rsquo;) <strong>allergy</strong> is a <strong>relative contraindication</strong> of this group of drugs.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Some of the important <strong>sulfa drugs</strong>:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">robenecid</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">elecoxib</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">F</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">urosemide</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">cetazolamide</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ulfonamide antibiotics</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ulfasalazine </span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">S</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ulfonylureas</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hiazides</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mnemonic: <strong>&ldquo;P</strong>lease <strong>cfast&rdquo;</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Side Effects: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paraesthesia (&lsquo;Pins and Needles&rsquo; sensation in the extremities)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malaise and Lowered Mood</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gastrointestinal Symptoms</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal Stones</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dose-Related Bone Marrow Suppression</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiosyncratic Aplastic Anaemia </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Mannitol&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>osmotic diuretic</strong> commonly used to <strong>reduce intraocular pressure</strong> in <strong>glaucoma</strong> or to <strong>reduce intracranial pressure</strong>. It does not contain sulfa and is <strong>generally safe</strong> for patients with <strong>sulfa allergies</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Prostaglandin (PG) Analogues&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are used in the <strong>treatment</strong> of <strong>glaucoma</strong> and <strong>work</strong> by <strong>increasing uveoscleral outflow</strong> to <strong>lower intraocular pressure</strong>. Prostaglandin analogues do not contain sulfa and are <strong>typically safe</strong> for patients with <strong>sulfa allergies</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Glycerol</strong> (or <strong>glycerine</strong>) is an <strong>osmotic agent</strong> used to <strong>lower intraocular pressure</strong>. It does not contain sulfa and is <strong>safe</strong> for <strong>patients</strong> with <strong>sulfa allergies</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, as it is a <strong>sulfa-based medication</strong> and can <strong>cause allergic reactions</strong> in patients with <strong>sulfa allergies</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kanski 9<sup>TH</sup> Edition Page 407</span></strong></span></span></p>",
      "correct_choice_id": 61071,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34740,
      "choices": [
        {
          "id": 138778,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Timolol </span></span></span></span></p>"
        },
        {
          "id": 138779,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dorzolamide </span></span></span></span></p>"
        },
        {
          "id": 138780,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Apraclonidine </span></span></span></span></p>"
        },
        {
          "id": 138781,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient underwent prophylactic Nd:YAG peripheral iridotomy. All of the following agents is prescribed to counter post procedure spike in IOP, except?</span></span></p>",
      "unique_key": "Q7322809",
      "question_audio": null,
      "question_video": null,
      "map_id": 31233,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Pilocarpine</span></span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pilocarpine, a <strong>cholinergic agonist</strong>, works by <strong>constricting</strong> the <strong>pupil</strong> and <strong>pulling</strong> the <strong>iris away</strong> from the <strong>trabecular meshwork</strong>, thus <strong>increasing aqueous humor outflow</strong>. However, in the context of <strong>post-iridotomy care</strong>, pilocarpine is the <strong>exception</strong>. The purpose of an iridotomy is to <strong>create</strong> an <strong>opening</strong> in the <strong>iris</strong> to <strong>relieve pupillary block</strong> and <strong>facilitate aqueous humor flow</strong>, <strong>rendering</strong> the action of <strong>pilocarpine</strong> (which aims to achieve a similar outcome <strong>through miosis</strong>) <strong>less relevant</strong> or <strong>even counterproductive post-iridotomy</strong>. The iridotomy itself should <strong>alleviate</strong> the <strong>mechanism</strong> that <strong>pilocarpine targets</strong>, and <strong>additional constriction</strong> of the <strong>pupil</strong> may <strong>not be beneficial</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Timolol as a <strong>beta-blocker</strong>, Timolol <strong>decreases aqueous humor production</strong>, thus <strong>lowering IOP</strong>. It is commonly used in <strong>glaucoma management</strong>, including after laser procedures, to control IOP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Dorzolamide, <strong>topical carbonic anhydrase inhibitor</strong> <strong>reduces</strong> <strong>IOP</strong> by <strong>decreasing aqueous humor production</strong>. It is also used in <strong>glaucoma management</strong> and can be used <strong>post-laser procedures</strong> to <strong>control IOP spikes</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Apraclonidine, an <strong>alpha-2 adrenergic agonist</strong> that <strong>reduces IOP</strong> by <strong>decreasing aqueous humor production</strong> and <strong>increasing uveoscleral outflow</strong>. It is specifically used to <strong>prevent</strong> or <strong>treat spikes</strong> in IOP after <strong>laser eye surgery</strong>, making it <strong>highly relevant</strong> in this context.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine is the <strong>exception</strong>, as it is <strong>less likely</strong> to be <strong>prescribed post Nd:YAG peripheral iridotomy</strong> to <strong>counter</strong> a <strong>spike</strong> in <strong>IOP</strong>, given that the procedure itself <strong>addresses</strong> the <strong>issue pilocarpine</strong> is used to manage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PARSONS DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 157</span></span></strong></span></span></p>",
      "correct_choice_id": 138781,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}